Abstract.
After phosphorylation by protein kinase A and in the presence of ATP, the cystic fibrosis transmembrane conductance regulator (CFTR) functions as a Cl– channel. In this study we have examined the effects of suramin on the CFTR Cl– current (ICFTR) in excised inside-out macropatches from Xenopus oocytes expressing human CFTR; glibenclamide, the standard inhibitor of ICFTR, and some congeners were tested in comparison.
ICFTR was activated by addition of the catalytic subunit of protein kinase A and MgATP to the bath. Suramin inhibited ICFTR with an IC50 value of 1 µM and a Hill coefficient close to 1; the inhibition showed little voltage dependence and was easily reversed upon washout of the drug. In comparison, glibenclamide inhibited ICFTR with an IC50 value of ≈20 µM. When tested against ICFTR in whole oocytes, bath application of suramin was ineffective whereas glibenclamide was about four times weaker than in the inside-out patch configuration.
The data show that suramin is the most potent inhibitor of CFTR yet described and suggest that the compound approaches its site of action from the cytosol.
Author information
Authors and Affiliations
Additional information
Electronic Publication
Rights and permissions
About this article
Cite this article
Bachmann, A., Russ, U. & Quast, U. Potent inhibition of the CFTR chloride channel by suramin. Naunyn-Schmiedeberg's Arch Pharmacol 360, 473–476 (1999). https://doi.org/10.1007/s002109900096
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s002109900096